Thu, March 2, 2023
Wed, March 1, 2023
Tue, February 28, 2023

Vamil Divan Initiated (CALT) at Hold and Held Target at $18 on, Mar 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-18-on-mar-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Guggenheim, Initiated "Calliditas Therapeutics AB (publ)" (CALT) at Hold and Held Target at $18 on, Mar 1st, 2023.

Vamil has made no other calls on CALT in the last 4 months.



There is 1 other peer that has a rating on CALT. Out of the 1 peers that are also analyzing CALT, 0 agree with Vamil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vamil


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $79 on, Friday, February 24th, 2023

Publication Contributing Sources